Freestone Grove Partners LP Haemonetics Corp Transaction History
Freestone Grove Partners LP
- $13.4 Trillion
- Q3 2025
A detailed history of Freestone Grove Partners LP transactions in Haemonetics Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 30,260 shares of HAE stock, worth $2.22 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,260Holding current value
$2.22 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
338Shares Held
50.2MCall Options Held
666KPut Options Held
395K-
Black Rock Inc. New York, NY5.96MShares$438 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$355 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY3.67MShares$270 Million0.14% of portfolio
-
Aqr Capital Management LLC Greenwich, CT2.13MShares$156 Million0.07% of portfolio
-
State Street Corp Boston, MA1.8MShares$132 Million0.0% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.77B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...